BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21788961)

  • 1. Theory and practice of informed consent in the Czech Republic.
    Krizova E; Simek J
    J Med Ethics; 2007 May; 33(5):273-7. PubMed ID: 17470503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consenting for Dialysis or Its Alternative: Systematic Process Is Needed.
    Li KC; Brown MA
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):560-562. PubMed ID: 32019760
    [No Abstract]   [Full Text] [Related]  

  • 3. What constitutes evidence-based patient information? Overview of discussed criteria.
    Bunge M; Mühlhauser I; Steckelberg A
    Patient Educ Couns; 2010 Mar; 78(3):316-28. PubMed ID: 20005067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis.
    Erdmann A; Rehmann-Sutter C; Bozzaro C
    BMC Med Ethics; 2021 Aug; 22(1):116. PubMed ID: 34465328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CE test 2.6 hours: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Contrada E
    Am J Nurs; 2011 Oct; 111(10):36-7. PubMed ID: 21955906
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging Therapies: Communication, Consent, and Collaboration in Research-Based Treatment.
    Stubbe DE
    Focus (Am Psychiatr Publ); 2018 Jul; 16(3):289-291. PubMed ID: 31975923
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors Associated With Levels of Public Engagement in Protective Behaviors During the Early COVID-19 Pandemic: Causal-Comparative Study Based on the Health Belief Model.
    Tang CC; Chen H; Tsai SY; Wu WW
    JMIR Hum Factors; 2023 Dec; 10():e49687. PubMed ID: 38113083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the Informed Consent Process Using Shared Decision Making and Consent Refusal Data from the CLEAR III Trial.
    Porter AL; Ebot J; Lane K; Mooney LH; Lannen AM; Richie EM; Dlugash R; Mayo S; Brott TG; Ziai W; Freeman WD; Hanley DF
    Neurocrit Care; 2020 Feb; 32(1):340-347. PubMed ID: 31571176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?
    Thylén I; Moser DK; Chung ML; Miller J; Fluur C; Strömberg A
    Int J Cardiol Heart Vessel; 2013 Dec; 1():22-31. PubMed ID: 29450154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].
    Ladwig KH; Ischinger NF; Ronel J; Kolb C
    Herzschrittmacherther Elektrophysiol; 2011 Sep; 22(3):151-6. PubMed ID: 21769624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
    Hess PL; Matlock DD; Al-Khatib SM
    Clin Cardiol; 2020 Feb; 43(2):187-195. PubMed ID: 31867773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' perceptions of shared decision-making for implantable cardioverter-defibrillators: Results of a physician survey.
    Ali-Ahmed F; Matlock D; Zeitler EP; Thomas KL; Haines DE; Al-Khatib SM
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2420-2426. PubMed ID: 31515880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective communication and ethical consent in decisions related to ICDs.
    Clark AM; Jaarsma T; Strachan P; Davidson PM; Jerke M; Beattie JM; Duncan AS; Ski CF; Thompson DR
    Nat Rev Cardiol; 2011 Jul; 8(12):694-705. PubMed ID: 21788961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.